Immunogenicity and safety of different doses of split, inactivated, trivalent influenza vaccine (Fluzone) administered by intradermal and intramuscular route in healthy adults (a randomized, prospective, active-controlled, single-center, open-label, dose-ranging study)

Trial Profile

Immunogenicity and safety of different doses of split, inactivated, trivalent influenza vaccine (Fluzone) administered by intradermal and intramuscular route in healthy adults (a randomized, prospective, active-controlled, single-center, open-label, dose-ranging study)

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Mar 2013

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top